We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$3.77M
Cap. Flow
-$171K
Cap. Flow %
-0.17%
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
36
Closed
61

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$1.85M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.67M
3
TSVT
2seventy bio
TSVT
+$1.59M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.37M
5
ADCT icon
ADC Therapeutics
ADCT
+$1.19M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$12.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.1M
3
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.08M
4
WBA
Walgreens Boots Alliance
WBA
+$1.6M
5
SNY icon
Sanofi
SNY
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 56.8%
2 Real Estate 15.08%
3 Financials 8.32%
4 Energy 6.75%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRE
226
DELISTED
Duke Realty Corp.
DRE
– –
-4,434
Closed -$214K
6 7 8 9
10

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, AlphaCentric Advisors held 226 positions worth $101M, up 3.9% from $97.4M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors's Q4 2022 filing shows 42 new, 62 increased, 36 reduced and 61 closed positions. Its largest new stake was Novavax: 105,000 shares worth $1.08M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 44% a quarter earlier, followed by Real Estate and Financials.

  • AlphaCentric Advisors's largest Q4 2022 buy was Novavax: 105,000 shares worth $1.08M.
  • AlphaCentric Advisors added most to 2seventy bio in Q4 2022, an estimated $1.59M increase.
  • AlphaCentric Advisors's biggest Q4 2022 reduction was Walgreens Boots Alliance, cutting an estimated $1.6M.
  • AlphaCentric Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q4 2022, selling an estimated $12.8M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $101M portfolio in Q4 2022.
  • AlphaCentric Advisors opened 42 new positions and closed 61 in Q4 2022.
  • AlphaCentric Advisors's portfolio value rose 3.9% quarter-over-quarter to $101M.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.